PHA Pharmagest Interactive SA

Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS

Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS

        

Villers-lès-Nancy, 10 June 2024 - 6:00 p.m. (CET)

PRESS RELEASE

ANNUAL ORDINARY GENERAL MEETING

MEETING NOTICE

ON-LINE AVAILABILITY OF MEETING MATERIALS

EQUASENS hereby provides notice to shareholders of the Annual Ordinary General Meeting to be held on Thursday, June 27, 2024 at 5.30 pm at the Company’s registered office located in Villers-lès-Nancy (Technopôle de Nancy-Brabois - 5 Allée de Saint Cloud).

The original French language version of the agenda and the resolutions submitted by the Board of Directors to the Ordinary Annual General Meeting were published in the French publication for legal announcements (Bulletin des Annonces Légales Obligatoires) on 17 May, 2024 (-officiel.gouv.fr/pages/balo-annonce-unitaire/?q.id=id_annonce:20240517240156460).

The Meeting Notice was published on the June 7, 2024 in the BALO (-officiel.gouv.fr/pages/balo-annonce-unitaire/?q.id=id_annonce:20240607240238969) and in the Official Journal “Les Tablettes Lorraines” () including the procedures for participating and voting and the main methods to exercise shareholders’ rights.

Both of these notices are available on the Company’s website: .

Pursuant to article R. 22-10-23 of the French commercial code, EQUASENS has also made available, since June 5, 2024, all the documents and information prescribed by this article and the voting form on its website - Section Investisseurs, Assemblée Générale tab. The English version of these documents is available on the company's website, by clicking on the EN icon in the Investors section: .

For the purpose of communications between the Company and its shareholders, it is strongly recommended that requests or documents be sent, in priority, by email, to the following address: .

About

With more than 1,300 employees, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.

With operations in France, Germany, Great Britain, Belgium, Ireland, Italy, and Luxembourg, Equasens Group today brings together healthcare professionals within a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

  

Listed on Euronext Paris™ - Compartment B

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable

Included in the Euronext Tech Leaders segment and the European Rising Tech label

Eligible for the Deferred Settlement Service (“Service à Règlement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME)

ISIN: FR 0012882389 – Ticker Code: EQS

Get all the news about the Equasens Group and on

CONTACTS

Analyst and Investor Relations:

Chief Administrative and Financial Officer: Frédérique SCHMIDT

Tel. +33 (0)3 83 15 90 67 -

Media Relations:

FIN’EXTENSO - Isabelle APRILE

Tel. +33 (0)6 17 38 61 78 -   

Attachment



EN
10/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pharmagest Interactive SA

 PRESS RELEASE

Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE A...

Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS          Villers-lès-Nancy, 10 June 2024 - 6:00 p.m. (CET) PRESS RELEASE ANNUAL ORDINARY GENERAL MEETING MEETING NOTICE ON-LINE AVAILABILITY OF MEETING MATERIALS EQUASENS hereby provides notice to shareholders of the Annual Ordinary General Meeting to be held on Thursday, June 27, 2024 at 5.30 pm at the Company’s registered office located in Villers-lès-Nancy (Technopôle de Nancy-Brabois - 5 Allée de Saint Cloud). The original French language version of the agenda and the resolution...

 PRESS RELEASE

EQUASENS : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE - AVIS DE CONVOCATION...

EQUASENS : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE - AVIS DE CONVOCATION - MISE EN LIGNE DES DOCUMENTS PREPARATOIRES Villers-lès-Nancy, le 10 juin 2024 – 18 :00 (CET) COMMUNIQUE DE PRESSE ASSEMBLEE GENERALE ORDINAIRE ANNUELLE AVIS DE CONVOCATION MISE EN LIGNE DES DOCUMENTS PREPARATOIRES La société EQUASENS invite ses actionnaires à participer à l’Assemblée Générale Ordinaire Annuelle qui se réunira le jeudi 27 juin 2024, à 17 heures 30, au Siège Social à Villers-lès-Nancy (Technopôle de Nancy-Brabois - 5 Allée de Saint Cloud). L'avis de réunion préalable, comprenant notamment l'ordre ...

LOIC WOLF
  • LOIC WOLF

EQUASENS (EQS) - CA T1 2024 : Début d'année tendu / Achat - Obj. 76,4 ...

CA Groupe 53,3 M€ -5,2% (-6,7% à périmètre comparable) ; Apport acquisitions +2 M€ ; Effet Ségur +0,3 M€ vs +1,4 M€ au T1 2023 ; Légère reprise de la croissance au S2 ; Accélération « significative » en 2025.

 PRESS RELEASE

Equasens: Q1 2024 revenue

Equasens: Q1 2024 revenue Villers-lès-Nancy, 7 May 2024 - 6:00 p.m. (CET) PRESS RELEASE Q1 2024 revenue: €53.3 million Contributions from new acquisitions offset the base effect from the Ségur digital healthcare investment programme.The Divisions that sell equipment are heavily impacted by the economic context. 2024 outlook: after a phase of significant investment, the Group is targeting a return to growth beginning in H2. Q1 revenue (€m)2023 reported basis2024 reported basisChange / Reported basis- Ségur2024+Ségur2023- External growthChange / Like-for-like Group56.253.3-2.9-5.2%0.31.4...

 PRESS RELEASE

EQUASENS : Chiffre d’affaires T1 2024

EQUASENS : Chiffre d’affaires T1 2024 Villers-lès-Nancy, le 7 mai 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires T1 2024 à 53,3 M€ La contribution des croissances externes équilibre l’effet de base du SégurLes Divisions commercialisant du matériel sont fortement impactées par la conjoncture économique Perspectives 2024 : Le Groupe, après une phase d’investissements forte, compte renouer avec la croissance à compter du S2 T1 (M€)Publié 2023Publié 2024Variation / Publié- Ségur 2024+ Ségur 2023- Croissances externesVariation / Périmètre comparableGroupe56,253,3-2,9-5,2%0,31,42...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch